New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2019, Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV: policy update 2019
View latest version (2019)Bibliographic Info
Guideline—
Year of Publication—
Issuing Institution—
Recommendation
Status
Retired
Recommended against
Strong
Certainty of evidence
Very low
lateral flow urine lipoarabinomannan assay (LF-LAM) should not be used as a screening test for active TB
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach
Year2016
InstitutionWHO